Can asymptomatic patients with a supratherapeutic international normalized ratio be safely treated as outpatients?

Ann Emerg Med. 2012 Apr;59(4):318-20. doi: 10.1016/j.annemergmed.2011.04.023. Epub 2011 May 31.
No abstract available

Publication types

  • Review

MeSH terms

  • Ambulatory Care*
  • Anticoagulants / adverse effects*
  • Asymptomatic Diseases / therapy*
  • Blood Coagulation Disorders / blood
  • Blood Coagulation Disorders / chemically induced*
  • Blood Coagulation Disorders / diagnosis
  • Blood Coagulation Disorders / therapy
  • Humans
  • International Normalized Ratio*
  • Risk Assessment
  • Warfarin / adverse effects*

Substances

  • Anticoagulants
  • Warfarin